OSE Immunotherapeutics publie sa position de tresorerie au 30 juin 2025
(Paris:OSE), OSE Immunotherapeutics Reports its Cash Position as of June 30, 2025 Nantes, France, September 25, 2025, 6 p.m. CET – OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE) reports its cash position as of June 30, 2025. Due to the Company's Annual General Meeting being rescheduled to September 30, 2025, and to allow shareholders to […]